---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-027621"
form_type: "8-K/A"
ticker: "RVPH"
cik: "0001742927"
company_name: "REVIVA PHARMACEUTICALS HOLDINGS, INC."
filed_at: "2024-08-22T23:59:59+00:00"
generated_at: "2026-05-31T08:06:03.781039+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Reviva Pharmaceuticals raises $3.8M net in public offering of common stock and warrants

## Summary
- Net proceeds from offering updated to $3.8M; closed Aug 22, 2024.
- Sold 3,276,262 shares at $1.05/share along with warrants to purchase up to 4,761,905 shares at $0.7964.
- Also issued pre-funded warrants for 1,485,643 shares and underwriter warrants for 238,095 shares at $1.3125.
- Existing warrants from 2021 and 2023 amended: exercise price lowered to $0.7964, expiration extended to 5 years.
- Titan Partners Group underwriter; 8.0% commission and expense reimbursement.

## SEC filing metadata
- accession: 0001437749-24-027621
- form_type: 8-K/A
- ticker: RVPH
- cik: 0001742927
- company_name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
- filed_at: 2024-08-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1742927/000143774924027621/0001437749-24-027621-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1742927/000143774924027621/rvph20240822_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-027621
- JSON: https://secwatch.observer/filing/0001437749-24-027621.json
- Plain text: https://secwatch.observer/filing/0001437749-24-027621.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.